Spaulding Clinical Research Announces Addition to Cardiac Core Lab Management Team

West Bend, WI, June 09, 2016 --(PR.com)-- Spaulding Clinical Research, LLC, a global clinical pharmacology, cardiac safety and biometrics solutions provider, today announced the addition of Shane Braninburg as Senior Director of Core Lab Services. Mr. Braninburg brings more than 15 years of global business expertise to Spaulding, including extensive operational and management experience at two of the largest cardiac core labs in the world.

Prior to joining Spaulding Clinical Research, Mr. Braninburg was the Senior Director of Business Process Improvement at ERT, where he was responsible for launching ERT’s centralized surveillance product across respiratory, cardiac and clinical outcome lines of business. His previous roles at ERT include Senior Director of Site Management and Director of Operations, Digital ECG Laboratory.

“Shane is a proven strategic planner with the skills needed to complement our rapid growth and sustain the quality of work our clients’ expect,” said Randol Spaulding, Founder and CEO of Spaulding Clinical Research. “With the recent FDA 510(k) Clearance of our 12-lead Bluetooth™ electrocardiograph device and the addition of Shane to the team, we’re delivering the innovative solutions the industry is looking for and the expertise necessary to deliver results.”

About Spaulding Clinical Research, LLC

Spaulding Clinical Research, LLC is a global CRO providing Phase I - IV drug development services to the biotechnology and pharmaceutical industries. Spaulding Clinical Research operates a 200-bed Clinical Pharmacology Unit, Cardiac Core Laboratory and provides full Biometrics/Scientific Affairs services.